← Leaderboards
Yi Xu
Texas A&M University Health Science Ctr
$4,300,246
Attributed
$4,300,246
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $618.2K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,300,246 · 7
By mechanism
R01$2,260,235 · 2
R21$2,040,011 · 5
Top collaborators
No co-investigators on record.
Most similar at Texas A&M University Health Science Ctr
Same institution · by research overlap
- Paul D Gershon$6,073,054
- Rajesh C Miranda$10,546,165
- Farida Sohrabji$12,744,048
- David E Dostal$2,264,687
Others in their field
Top investigators on “Mediating”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$493,822,581
- Barton F Haynes · Duke University$295,802,493
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$286,700,869
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$176,977,598
- Dan H. Barouch · Fred Hutchinson Cancer Center$122,734,499
Research focus
MediatingMicrobialProteinsMolecularFutureRecombinant ProteinsPathogenInfectionIn VivoBiologicalCellsEpithelial CellsEpitheliumPlayLeadReportingAffectLifeColorectal CancerHuman PathogenPathogenesisAnimalsIn VitroMutant
Grant awards (18)
Type VII secretion in Streptococcus gallolyticus pathogenesis$366,305
R01 · FY2025 · AI · contact PI
Type VII secretion in Streptococcus gallolyticus pathogenesis$78,152
R01 · FY2025 · AI · contact PI
Type VII secretion in Streptococcus gallolyticus pathogenesis$377,231
R01 · FY2024 · AI · contact PI
Type VII secretion in Streptococcus gallolyticus adherence$220,309
R21 · FY2024 · AI · contact PI
Diversity Supplement: Type VII secretion in Streptococcus gallolyticus pathogenesis$20,652
R01 · FY2024 · AI · contact PI
Type VII secretion in Streptococcus gallolyticus adherence$183,649
R21 · FY2023 · AI · contact PI
Activation of TGFbeta by a gut pathobiont$228,420
R21 · FY2021 · AI · contact PI
Activation of TGFbeta by a gut pathobiont$196,258
R21 · FY2020 · AI · contact PI
Manipulation of host complement by Clostridium difficile spores - an immune evasion strategy.$222,750
R21 · FY2017 · AI · contact PI
Manipulation of host complement by Clostridium difficile spores - an immune evasion strategy.$185,625
R21 · FY2016 · AI · contact PI
Bacillus Anthracis and Complement$356,725
R01 · FY2015 · AI · contact PI
Bacillus Anthracis and Complement$356,712
R01 · FY2014 · AI · contact PI
Bacillus Anthracis and Complement$339,832
R01 · FY2013 · AI · contact PI
Bacillus Anthracis and Complement$364,626
R01 · FY2012 · AI · contact PI
The Role of Lung Epithelium in B. anthracis Pathogenesis$219,750
R21 · FY2010 · AI · contact PI
The Role of Lung Epithelium in B. anthracis Pathogenesis$183,125
R21 · FY2009 · AI · contact PI
Cell wall protein in Bacillus anthracis pathogenesis$218,250
R21 · FY2005 · AI
Cell wall protein in Bacillus anthracis pathogenesis$181,875
R21 · FY2004 · AI